Skip to content

Cart

YOUR CART IS EMPTY

Add research compounds to begin your order.

CONTINUE SHOPPING
Human clinical and physiological evidenceSee approved evidence mapCompleted

Journal of Acquired Immune Deficiency Syndromes

TES-STUDY-P013

Falutz J, Potvin D, Mamputu J-C, et al. Effects of tesamorelin in HIV-infected patients with excess abdominal fat. Journal of Acquired Immune Deficiency Syndromes. 2010. DOI: 10.1097/QAI.0b013e3181cbdaff. PMID: 20101189. NCT00435136. https://pub

Study design

Record details

Design
Human clinical and physiological evidence

Evidence record

Endpoints, findings, and limitations

Reports and sources

Reference ledger

  1. P013Human clinical and physiological evidence

    Journal of Acquired Immune Deficiency Syndromes

    Falutz J, Potvin D, Mamputu J-C, et al. Effects of tesamorelin in HIV-infected patients with excess abdominal fat. Falutz J, Potvin D, Mamputu J-C, et al. Effects of tesamorelin in HIV-infected patients with excess abdominal fat. Journal of Acquired Immune Deficiency Syndromes. 2010. DOI: 10.1097/QAI.0b013e3181cbdaff. PMID: 20101189. NCT00435136. https://pubmed.ncbi.nlm.nih.gov/20101189/(2010). DOI: 10.1097/QAI.0b013e3181cbdaff